These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35595574)

  • 41. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
    Bae T; Hur JW; Kim D; Hur JK
    Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Research progress of visual detection in rapid on-site detection of pathogen nucleic acid.
    Liu DN; Wu HP; Zhou GH
    Yi Chuan; 2023 Apr; 45(4):306-323. PubMed ID: 37077165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRISPR Approaches for the Diagnosis of Human Diseases.
    Puig-Serra P; Casado-Rosas MC; Martinez-Lage M; Olalla-Sastre B; Alonso-Yanez A; Torres-Ruiz R; Rodriguez-Perales S
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergetic performance of isothermal amplification techniques and lateral flow approach for nucleic acid diagnostics.
    Mukama O; Nie C; Habimana JD; Meng X; Ting Y; Songwe F; Al Farga A; Mugisha S; Rwibasira P; Zhang Y; Zeng L
    Anal Biochem; 2020 Jul; 600():113762. PubMed ID: 32387190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The era of Cas12 and Cas13 CRISPR-based disease diagnosis.
    Singh M; Bindal G; Misra CS; Rath D
    Crit Rev Microbiol; 2022 Nov; 48(6):714-729. PubMed ID: 35164636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRISPR/Cas Multiplexed Biosensing: A Challenge or an Insurmountable Obstacle?
    Li Y; Liu L; Liu G
    Trends Biotechnol; 2019 Aug; 37(8):792-795. PubMed ID: 31153632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel nucleic acid detection strategies based on CRISPR-Cas systems: From construction to application.
    Zhu CS; Liu CY; Qiu XY; Xie SS; Li WY; Zhu L; Zhu LY
    Biotechnol Bioeng; 2020 Jul; 117(7):2279-2294. PubMed ID: 32175589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FELICX: A robust nucleic acid detection method using flap endonuclease and CRISPR-Cas12.
    Aggarwal N; Liang Y; Foo JL; Ling H; Hwang IY; Chang MW
    Biosens Bioelectron; 2023 Feb; 222():115002. PubMed ID: 36527830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
    Yu C; Mo J; Zhao X; Li G; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The CRISPR-Cas app goes viral.
    Lemay ML; Horvath P; Moineau S
    Curr Opin Microbiol; 2017 Jun; 37():103-109. PubMed ID: 28623719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A short overview of CRISPR-Cas technology and its application in viral disease control.
    Ghorbani A; Hadifar S; Salari R; Izadpanah K; Burmistrz M; Afsharifar A; Eskandari MH; Niazi A; Denes CE; Neely GG
    Transgenic Res; 2021 Jun; 30(3):221-238. PubMed ID: 33830423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Application and optimization of CRISPR/Cas system in bacteria].
    Fu J; Yang F; Xie H; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic efficiency of RT-LAMP integrated CRISPR-Cas technique for COVID-19: A systematic review and meta-analysis.
    Bhatt A; Bumbrah GS; Ruwali M; Hameed S; Fatima Z
    Pathog Glob Health; 2022 Oct; 116(7):410-420. PubMed ID: 35142264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.
    Zhan Y; Li XP; Yin JY
    Int J Biol Sci; 2021; 17(8):2080-2088. PubMed ID: 34131407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of the CRISPR/Cas System in Pathogen Detection: A Review.
    Yuan B; Yuan C; Li L; Long M; Chen Z
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rational designs of in vivo CRISPR-Cas delivery systems.
    Xu CF; Chen GJ; Luo YL; Zhang Y; Zhao G; Lu ZD; Czarna A; Gu Z; Wang J
    Adv Drug Deliv Rev; 2021 Jan; 168():3-29. PubMed ID: 31759123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
    Dong W; Kantor B
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
    Qiu M; Glass Z; Xu Q
    Biomacromolecules; 2019 Sep; 20(9):3333-3339. PubMed ID: 31342740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR/Cas systems: opportunities and challenges for crop breeding.
    Biswas S; Zhang D; Shi J
    Plant Cell Rep; 2021 Jun; 40(6):979-998. PubMed ID: 33977326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.